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Abstract
Background: There is a growing ethical imperative to feedback research results to participants but there remains a
striking lack of empirical research on how people respond to individualised feedback. We sought to explore
longitudinal study participants’ response to receiving individual written feedback of weight-related and blood
results, and to consider the balance of harms against benefits.
Methods: A qualitative study with face-to-face and telephone interviews conducted with 50 men and women
who had participated in the fifth and most recent wave of the cohort study ‘West of Scotland Twenty-07’ and
received a feedback letter containing body mass index (BMI), body fat percentage, cholesterol and glycated
haemoglobin A1c (HbA1c) results.
Results: Expectations of, and response to, the feedback of their individual results varied. Whilst half of the
participants were on the whole ‘pleased’ with their results or held neutral views, half reported negative responses
such as ‘shock’ or ‘concern’, particularly in relation to the weight-related results. Participants who were overweight
and obese used the most negative language about their results, with some being quite distressed and reporting
feelings of powerlessness, low self-image and anxiety over future health. Nevertheless, some people reported
having implemented lifestyle changes in direct response to the feedback, resulting in significant weight-loss and/or
dietary improvements. Others reported being motivated to change their behaviour. Age and gender differences
were apparent in these narratives of behaviour change.
Conclusions: The potential harm caused to some participants may be balanced against the benefit to others.
More evaluation of the impact of the format, content and means of individualised feedback of research findings in
non-trial studies is required given the growing ethical imperative to offer participants a choice of receiving their
results, and the likelihood that a high percentage will choose to receive them.
Background
The issue of returning research results to participants
has been receiving increasing attention internationally
[1], and the evidence-base on this has grown in the past
decade [2]. Largely an ethical debate, the key issue has
been whether it is appropriate to deny participants their
results [3]. Despite this debate, confusion surrounds the
issue of feeding back data to research participants, in
part due to: the plethora of national and international
ethics guidelines that exist [1]; few exploratory studies
that report participants’ experiences of receiving feed-
back at all, with a particular lack of research on partici-
pants’ views towards receiving individualised feedback
[4]; and variation in the reported ethical balance of ben-
eficence (intent to benefit) against nonmalefience (intent
not to harm) [5,6]. It is important to continue to exam-
ine the potential that feedback has for harm as well as
good, so that any feedback given is ethically robust and
avoids becoming a simple box-ticking exercise.
There has been a ‘mushrooming’ of interest - and
indeed policy within the United Kingdom (UK) context
[7,8] - around whether and how to feed back data to
participants of clinical trials. The Medical Research
Council (MRC) in the UK, for example, has produced
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guidelines on the use of human tissue and biological
samples, which recommended that research participants
have the right ‘to know individual research results that
affect their interests’, adding they ‘should be able to
choose whether to exercise that right.’ [7] Despite the
increasing interest, there remains a stark paucity of evi-
dence on participants’ responses to receiving feedback.
A recent (non-systematic) review found eight studies
which empirically examined the response to feedback,
but seven concerned aggregate results and no commu-
nity-based study was included [4]. An editorial in the
British Medical Journal in 2006 [9] called for more
research into ‘nuances in other types of study design’ (i.
e. non-trial studies) and other authors have recom-
mended that more empirical work be carried out into
the impact on participants of receiving research results
[2,5,10,11]. We sought to explore the possible benefits
and harms of the feedback given to participants in the
longitudinal ‘West of Scotland Twenty-07 Study’.
Methods
We conducted in-depth interviews with men and
women who had participated in the fifth and most
recent wave of data collection for the ‘West of Scotland
Twenty-07 Study: Health in the Community’, a 20-year
longitudinal study based in the Greater Glasgow area,
UK [12]. The Twenty-07 Study began in 1987 and has
followed three age cohorts born 20 years apart (in the
early 1970s, 1950s and 1930s). Detail on the study can
be found elsewhere [12], but briefly the main waves of
data collection have included an extensive face-to-face
interview by a trained nurse interviewer that covered:
self-reported health and health care use; a number of
mental health scales; family, social and economic cir-
cumstances; behaviours; life events; opinions; and an
intelligence test. In addition, a number of physical mea-
sures have been taken including: height; weight; waist
and hip circumferences; lung function; blood pressure;
pulse; and reaction times. Blood samples were added to
the suite of physical measures in wave 5, which was car-
ried out between September 2007 and October 2008.
Twenty-07 Study participants have always received
immediate feedback of their blood pressure from the
nurse interviewer at the time of their interview. In addi-
tion, all participants have received periodic aggregate
Study results in the form of a newsletter. During wave
5, participants were given the option of receiving their
individual physical measures (height, weight, BMI, body
fat percentage (measured using Bioelectrical Impe-
dance)) and blood results (total and HDL cholesterol,
and their ratio, and glycated haemoglobin A1c (as a per-
centage)) in a feedback letter. Of the 95% (n = 2, 425)
of all wave 5 Twenty-07 Study participants who
requested a feedback letter, most received it around
three months after their interview. Nearly all of those
people who chose not to receive feedback did not pro-
vide a blood sample. They were slightly more likely to
be female, from the younger cohort and from manual
social classes compared with the 95% who wished to
receive their feedback letter; they also were more likely
to be overweight and have high levels of body fat. Blood
results were more likely to be elevated among the few in
this group who had any blood results.
The weight-related and blood measures given in the
letters were put into context for participants; for exam-
ple, the words ‘underweight’, ‘normal’ and ‘overweight’
were used in relation to the BMI result; for body fat the
normal range for men and women was provided; and
for the two blood results respondents were recom-
mended to see their general practitioner (GP) if their
results were over levels set by the Study’s clinical advi-
sors and agreed by the ethics committee (see Table 1).
The Twenty-07 Study set the BMI cut-offs for the feed-
back letter at <19 for underweight, 19-27 for normal
and ≥ 27 for overweight, on advice from Twenty-07
Study Clinical Advisers. However, although in the feed-
back letter ‘normal’ BMI was defined as having a BMI of
less than 27, for this study we used the World Health
Organization (WHO) definition with an upper limit 25.
We therefore did not include those respondents with a
BMI of 25 to 27 in the overweight group as this is not
what the letter told the respondents. The overweight
group therefore started at a BMI of 27.
This qualitative study involved in-depth interviews
(both face-to-face and telephone) with participants who
had received a feedback letter from the Twenty-07
Study in the previous six months. Ethics approval was
granted from the University of Glasgow’s Faculty of
Law, Business and Social Sciences Ethics Committee.
We sought to recruit equal numbers of: men and
women; three BMI groups (normal, overweight and
obese); and, two age cohorts (1970s and 1950s). We also
sought to conduct equal numbers of face-to-face and
telephone interviews to explore any potential respondent
bias that might have been associated with the visible
weight status of the two researchers (both with normal
BMI, and both female aged in their 30s and 40s). Forty-
eight interviews were planned, but two extra interviews
with overweight men were carried out to include men
with a BMI >27 and high body fat, as two of the orignal
interviewees sampled in this group had a BMI >27 but
low body fat.
A total of 535 participants (from 2,604 in wave 5)
were eligible to participate in this qualitative follow-up
study, based on the following eligibility criteria: they had
received a feedback letter in the previous six months;
they were from the 1950s or 1970s cohorts; they had
not been excluded from any measure based on the
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fieldwork protocol (e.g. pregnant women); and, they had
received a standard feedback letter (rather than one
with an additional sentence inserted at the request of
our clinical advisers to convey an additional result from
the blood test results, for example, vitamin deficiency).
Estimating a 1 in 4 response to mailed invitations, based
on previous Twenty-07 qualitative sub-sample studies,
we sent a total of 377 invitations (randomly selected
from those eligible); the response was 21.2% (n = 80),
with variation by age and BMI. Of these, 50 interviews
were carried out (the remaining 30 were not required as
we had interviewed to our quota within each target
group). Most face-to-face interviews were carried out in
the participant’s home (the two exceptions were con-
ducted in University settings); all, except one, telephone
interviews were carried out with the participant at home
(one participant was on a mobile phone travelling as a
car passenger during the interview).
This study was part of a collaborative project funded
by Cancer Research UK (CRUK), which aimed to inves-
tigate response to being informed of weight status and
to different issues around weight-related terminology -
data on the latter will be reported elsewhere. The inter-
view questions pertaining to expectations of and
response to feedback are given in Table 2. Interviews
were audio-recorded (with consent obtained in writing
for face-to-face interviews and audio-recorded for tele-
phone interviews) and transcribed verbatim. Transcripts
were analysed using the Framework Approach, where
data are coded, indexed and charted systematically, then
organised using a matrix or framework [13]. The matrix
contained a row for each participant and a column for
each theme. A benefit of this approach is that it is very
transparent and allows interpretations to be viewed and
assessed by others. Framework analysis begins deduc-
tively from the study aims and objectives, with results
being grounded (in accounts) and inductive [14]. KL,
CG and MB read all transcripts; KL conducted the early
coding, which was discussed with two other researchers
(CG and MB) as a form of double coding. Constant
comparison was carried out to check for deviant cases
as well as similarities, in an iterative process. QSR
NVivo8 software was used to assist the systematic data
analysis and organisation. During analysis, we explored
participants’ attributes (e.g. gender, age), in which we
had an a priori interest, against the various themes to
rigorously explore emergent patterns in response by age
and gender.
In the next section, quotations will be followed with
the type of interview, participants’ key attributes and
their physical measures (BMI and body fat) and blood
results (ratio of cholesterol and whether the diabetes
test was normal or high) in the language fed back to
them in the letter - e.g. Tel 2, Female, age 55, over-
weight, BF normal, chol high, HbA1c normal. Abbrevia-
tions will be used: BF for body fat and chol for ratio of
cholesterol.
Results
Table 3 shows how the 50 interviewees compare to all
Twenty-07 Study participants. The majority of the 50
participants had participated in all 5 waves (78.0%, com-
pared with 69.8% of all Twenty-07 Study participants)
and were mostly from professional households (58.0%,
Table 1 Sentences given in the feedback letters
Sentence in feedback letter
BMI (kg/m2)
<19 This suggests that you might be underweight.
19-26.9 This suggests that your weight is probably normal
≥27 This suggests that you might be overweight.
Body composition All letters Studies have suggested that the recommended percentage of body fat is around 20-31% for women and 13-
21% for men.
Cholesterol (ratio of total to HDL
cholesterol)
≤4 This is within the normal range.
>4 (no statin reported) This is a little high and you may wish to consult your GP about the results.
>4 (statin reported) This is a little high but we note that you reported taking statins and we assume you and your GP are
monitoring this.
HbA1c
<6% This is within the normal range.
≥6% (no diabetes reported) This seems to be a little high and we recommend that you have your blood glucose level checked by your
general practitioner or practice nurse. You should not eat or drink before you undertake this test, please ask
your practice for advice on this when you make your appointment.
≥6% (diabetes reported) This seems to be a little high but we note that you are aware of your diabetes and assume that you and
your GP are monitoring this.
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Table 2 Topic guide (selected questions that investigated participants’ experiences of receiving individualised
feedback following their wave 5 Twenty-07 interview)
Did you have any expectations of what your results might have been? (Probe, explore what they were)
When you got your letter through, and you read over it, what was your initial reaction to your results? (Explore interpretation of each result)
Did you discuss your results with anyone? (Probe who, what was said...)
Did your results make you think differently about yourself? In what way?
Have you taken any action (done anything) in response to your results? What and why?
What are your views towards taking part in the Twenty-07 Study?
What, in general, did you think about being offered the feedback after your last interview?
Table 3 Characteristics of participants in current study and wave 5 of Twenty-07 Study
Male Female All sub-study
participants
n = 50 (%)
All other wave 5 Twenty-
07 participants (1970s
and 1950s cohorts)
n = 1864 (%)
P value for chi-square
BMI category (% ) Range* (% ) Range* N 0.002
Normal (19.0 to 24.9) 8 8 (32.0) 19.9 - 24.0 (26.6) 19.1 -25.0 492
Overweight (27.0 to 29.9) 10 8 (36. 0) 27.1 - 29.8 (22.2) 27.0-30.0 413
Obese (30.0 +) 8 8 (32.0) 30.1 - 44.6 (29.6) 30.0-63.4 558
Not eligible † - - - (21.5) 401
% Body Fat 0.315
Within quoted ranges (see Table 1) 9 5 (28.6)
Men 16.0-20.4
Women 27.2-30.9
(24.1)
Men 13.0-21.0
Women20.2-30.9
449
Above quoted ranges 16 19 (71.4)
Men21.6-33.0
Women 31.1-53.1
(68.5)
Men 21.1 -50.9
Women 31.1-61.7
1276
Not eligible ¥ 1 - - (7.4) 139
Cholesterol 0.061
Normal (≤4 mmol/L) 11 17 (57.1) 2.3 - 3.9 (47.5) 1.80-4.0 886
High (>4 mmol/L) 14 7 (42.9) 4.1 - 7.9 (39.2) 4.1-12.3 731
Missing 1 (13.3) 247
HbA1c 0.060
Normal (<6%) 24 22 (93.9) 4.3 - 6.0 (81.3) 3.4-6.0 1516
High (≥ 6%) 1 2 (6.1) 6.1 - 9.5 (5.2) 6.1-13.6 96
Missing 1 (13.5) 252
Registrar General’s Social Class for head of household Percentage Percentage 0.585
Professional/managerial household (I&II) 16 13 58.0 49.0 913
Skilled workers (IIIn-m and man) 9 7 32.0 36.5 681
Semi or unskilled household (IV&V) 1 4 10.0 13.8 257
Missing - - - 0.7 13
Wave participation Percentage Percentage 0.125
Taken part in all 5 waves 21 18 78.0 69.8 1314
Missed 1 wave 1 2 6.0 17.0 311
Missed more than 1 wave 4 4 16.0 13.1 239
* Numbers rounded to 1d.p.
† Those with missing data, underweight or overweight with BMI between 25 and 27.
¥ Those with missing data or body fat less than ‘normal range’.
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compared with 49.0% of all wave 5 participants),
although none of these differences were statistically sig-
nificant at the 95% level.
Expectations of results
Before discussing their response to the results in their
feedback letter, participants were invited to reflect on
any expectations they had about their letter. A range of
expectations were discussed. One group of participants
did not give the letter any thought in the period
between the main study interview and receiving the let-
ter, or impassively described their expectations.
I had no concerns or anything, so I was quite, yeah,
I’d kind of forgotten about it, to be honest, until it
came through. (Int 14, Female, age 35, normal
weight, BF normal, chol normal, HbA1c normal)
Around one in three participants offered such a
description of their expectations, with slightly more
older participants and women expressing these
expectations.
A second group of participants were not anxious, but
actually quite positive when describing their expectations.
This group tended to report being quite healthy and
health conscious (e.g. to describe eating healthily and
watching their weight) or report having a health condi-
tion and be in regular attendance at their GP or other
health professional, thus making them aware of their
health status in relation to weight and/or cholesterol:
No, I wasn’t worried at all, I was looking forward to
it... I know a lot about food, I’ve been a vegetarian
since I was [young age], so I’m quite good at it... I
know how to read a food package, I know what’s in
things and to me that’s common knowledge; I can’t
eat something without investigating it first. (Int 24,
Female, age 35, normal weight, BF normal, chol nor-
mal, HbA1c normal)
I didn’t expect any great shocks, because I’m one of
these people who have over the years had a great
deal of medical attention one way or the other
through the NHS, and probably I was well moni-
tored. (Int 22, Male, age 55, normal weight, BF nor-
mal, chol normal, HbA1c high)
Some men in this group considered that the physical
measures and blood test had been like having a ‘free
medical’ (Int 22, Male, age 55, normal weight, BF nor-
mal, chol normal, HbA1c high), which they welcomed.
A third group, around a quarter of all participants,
revealed slight concerns or anxieties about receiving
high results, either in general terms ‘I had a vague idea
what was going to be in it [letter], that it was probably
not going to be good.’ (Int 11, Female, age 35, over-
weight, BF high, chol normal, HbA1c normal), or specifi-
cally about either the physical measures or the blood
results:
I was a wee bit concerned that my cholesterol might
be high... I was a wee bit concerned I was getting
quite diabetic because again my sugar level was
quite high so that was a slight concern.(Tel 20,
Male, age 55, overweight, BF high, chol high, HbA1c
normal).
Five of these participants used the word ‘concerned’
about their impending results and were tentatively
expecting negative results (’think’ they will be bad);
others were more definite in their expectations of nega-
tive results. Women more often than men spoke nega-
tively about their expectations. There were no
differences by age.
More participants described not knowing what to
expect from their blood results than from their weight-
related results. Despite some reported anxieties about
blood results, what emerged clearly in participants’ nar-
ratives of their negative expectations was the greater
emphasis in discussions of their weight results, even
among those who reported never having had their cho-
lesterol tested before. The few participants who were
apprehensive about their blood results also spoke of
concern about their weight-related results.
Initial response to results
Participants’ response to results did not always match
with their prior expectations. Overall, half of partici-
pants’ descriptions of their initial response were not in
line with their expectations: some received better feed-
back than expected whereas some received worse.
Fifteen participants received results which were either
better than expected or confirmed their positive expec-
tations, so their result either made no difference to
them or caused them to feel ‘happy’, ‘glad’ or ‘pleased’.
One man who ‘didn’t expect any great shocks’ later
described his initial response:
I was really pleased that all the indications were that
I was absolutely where I should be for my age and
height and I was really quite gratified about all that.
(Int 22, Male, age 55, normal weight, BF normal,
chol normal, HbA1c high)
The complexity of narratives meant that some people
who were overweight or had a high total to HDL choles-
terol ratio were also pleased with their feedback results.
These participants often placed their results in the con-
text of prior ‘worse’ health, such as having a ratio of
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cholesterol of 7 mmol/l in the past and receiving a
result of 5 mmol/l in their feedback letter (even though
this had been fed back in their letter as ‘high’ with a
recommendation to visit their doctor).
I felt they were actually quite good; I was quite
happy with them... the [blood] result wasn’t as bad
as I thought it was going to be ... overall I was
happy with the results. (Tel 20, Male, age 55, over-
weight, BF high, chol high, HbA1c normal)
In contrast, ten participants who expressed neutral or
positive prior expectations went on to describe a nega-
tive initial response to their results. One woman
described being unconcerned in advance about receiving
her results as she believed herself to be ‘quite healthy so
I wasn’t really concerned’; however, she was taken aback
by her cholesterol and BMI results:
I was quite surprised when I did get it [letter]
through... I felt that my cholesterol was high... And
that I was over, well I knew I was overweight but I
think I was actually, I’m actually classed as obese
[respondent checked result on Internet]. (Tel 21,
Female, age 35, obese, BF high, chol high, HbA1c
normal).
Eight of these participants, almost all from the
younger age group, referred to the impact of seeing
their results in ‘black and white’. Seeing their results in
the letter felt stark, making them feel unable to ignore
their overweight or high cholesterol status.
I suppose seeing it in black and white, you know,
where you actually think, ‘Oh that is what that says’
and ‘God, I am fat!’ (Int 12, Female, age 35, over-
weight, BF high, chol normal, HbA1c normal).
For two participants, seeing their results in the letter
confirmed their positive expectations of ‘normal’ results
or offered no surprise to see a high result:
I’ve always known that my weight is classed as over-
weight so it didn’t really surprise me when I saw it
in black and white. (Int 2, Male, age 35, overweight,
BF normal, chol high, HbA1c normal).
Emotional response
Several participants revealed a strong negative emotional
response to their results. Women, in particular, often
used strong language to describe their initial response,
including being ‘shocked’, ‘concerned’ and ‘surprised’.
One 55 year old woman (Int 9, Female, age 55, obese,
BF high, chol normal, HbA1c normal) cried when
describing her weight-related results.
Within these emotional responses, participants were
frequently candid in their summation of their initial
reaction to their results:
Every bit of information in there (apart from height),
em BMI, the body fat composition, was just dreadful.
Half of me is fat. More than half of me probably.
Can’t remember exactly, but half of you is fat. You
know, and I think, ‘No. I’ve got all these bones as
well, and I’ve got lungs and I’ve ... No no, the major-
ity of you is fat’, you know. And you think [sighs],
‘No. No. This is just dreadful. I don’t want to be a
big ball of fat’. (Int 6, Female, age 35, obese, BF
high, chol high, HbA1c normal).
This forthrightness was more often expressed in rela-
tion to the weight-related results than the blood
results, even among participants who had received a
high cholesterol result. One 35 year old woman
received both a BMI and a cholesterol result that were
just into an ‘unhealthy’ category, but during her inter-
view she focused on being concerned about her weight
result:
...To think that you’re just young and you’re healthy
and you’re just carrying too much weight is quite...
aye, I was quite concerned about it actually. (Tel 21,
Female, age 35, obese, BF high, chol high, HbA1c
normal)
However, a few participants made light of their nega-
tive results.
Int: So seeing your weight result, how did you feel
about that?
Int 15: Well I know what the answer is there: I know
I could do better. It’s obvious, isn’t it? [2 secs]
Amputation’s all that’s left to me [laughs]. Maybe I
could get by without my head [laughing]. How
much does a head weigh?
(Int 15, Male, age 55, obese, BF high, chol high, HbA1c
normal)
Behavioural response
Several participants reported altering their lifestyles after
receiving their letter, citing it as motivating their beha-
viour change:
I think I was expecting it to be a little bit better. But
you know, I kind of eh, sometimes you can kid your-
self on a wee bit. So you think you’re doing better
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than you actually are. So it’s motivated me now a bit
more than I had done in the past, so I’m doing a lot
more exercise and eating a lot more healthier now.
[Sic] (Tel 7, Male, age 35, overweight, BF normal,
chol normal, HbA1c normal)
One woman reported that she had lost four stones
(~25 kilograms) since receiving her feedback letter; one
man reported losing over a stone (~6 kilograms). Most
(9/10) of those who reported behaviour change were in
the younger age group. However, more participants (15/
50) spoke about being motivated to make changes to
their diet and/or exercise as a result of receiving the
feedback, but admitted they had yet to implement any
change. Twelve of these participants were in the older
age group.
...as far as the BMI, etcetera, was concerned I wasn’t
surprised because I know that I’m overweight, I
know that I should try and lose weight but, as I say,
I don’t get obsessive about it because it just gets me
depressed. (Tel 22, Female, age 55, obese, BF high,
chol high, HbA1c normal).
Thus, it seems the ‘stark’ reality of seeing their results
in the letter seemed to resonate more with the younger
participants who subsequently appeared more likely to
take steps to change their health behaviour in compari-
son with the older participants.
It is also important to note that many participants
reported no change in behaviour as they had received
all ‘normal’ results and believed they were maintaining
their health so no modifications were required.
Understanding their results
Participants revealed a range of understandings of their
individual weight and blood results. The majority had a
general understanding of these results. Most understood
the BMI measure was a weight-related measure, but
whilst relating it to weight they often used words which
revealed their uncertainty:
I’m not really terribly sure exactly what it [BMI]
means. Does it mean that you’ve got too much fat you
know per whatever in proportion to what your frame
is, what your height is? (Int 17, Female, age 55, normal
weight, BF normal, chol normal, HbA1c normal).
Cholesterol results were generally perceived by partici-
pants to be related to diet and that the lower the better:
I’m not a really healthy eater, but I wouldn’t have
thought that I ate such a high fat content that would
push my cholesterol up. I don’t smoke, my drink is...
I drink moderately, so it was a wee bit surprising,
yes. (Tel 5, Male, age 35, overweight, BF normal,
chol high, HbA1c normal).
Although most could not recall their actual weight
and blood results in terms of the specific number, they
could recall whether their weight and blood results were
‘normal’ or ‘high’.
Whilst many were unable to explain the BMI mea-
sure beyond it being a weight-related measure, it
nevertheless resonated with many participants, whether
normal, overweight or obese. Other results were dis-
cussed less by participants. The body fat measure, in
particular, was rarely mentioned in any detail by parti-
cipants, who favoured discussing their BMI and ratio
of cholesterol. Even when prompted, participants often
could not remember their body fat result or failed to
understand the relevance of the percentage given to
them, despite being told of the ‘normal’ range in their
letters.
I don’t know, I don’t remember that result, if it was
33% I wouldn’t have any context, I don’t know how
good, bad or indifferent that is.
(Tel 9, Male, age 55, obese, BF high, chol high,
HbA1c normal)
Whilst understanding of the measures was often dis-
cussed in general terms, a few participants reported
more detailed knowledge, such as for the BMI cut-off
points:
Well above 25 you start to sweat and above 30 you
start to worry. (Tel 9, Male, age 55, obese, BF high,
chol high, HbA1c normal).
During discussions of their understanding, some parti-
cipants queried the validity of their result(s), in particu-
lar the BMI measure: eight men (BMI range 27.6 - 36.6)
rejected the BMI on the grounds that the measure does
not take into account fitness or muscle - features all of
these men believed they had. Four of the men had a
BMI in the overweight range but had normal body fat
measures; however, three of these men had a BMI in
the obese range, had elevated body fat and ratio of cho-
lesterol results which ranged from 4.8 to 7.2. One man
who was obese with a high body fat (30.6%) and high
cholesterol (4.8) reported:
I’m overweight but I’m not obese, I don’t think,
although technically I might be in the BMI thing,
which is, of course, tosh...if the BMI guy who wrote
the chart wants to race me, I will! (Int 15, Male, age
55, obese, BF high, chol high, HbA1c normal)
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Discussion
Despite the ethical imperative to offer research partici-
pants the choice of receiving study results, there remains
a striking lack of empirical research on how people
respond to individualised feedback, with the majority of
the literature focusing on feeding back aggregate study
data or, in the case of individualised results, to partici-
pants of genetics research [4,6]. Our study fed back indi-
vidual data to participants in a community sample; as
such, our examination of study participants’ expectations
and subsequent response to individual feedback adds
new and important knowledge to this field.
Our results reveal minimal harm done to some
respondents. We found no simple relationship between
feeding back a ‘negative’ result and having a correspond-
ing negative response or positive behaviour change.
Instead, a complex picture was found, which depended
on factors such as age, gender, expectations about
results and, drawing on the health education literature,
how the feedback in some cases interacted with indivi-
duals in different stages of health behaviour change
(precontemplation, contemplation, preparation, action
and maintenance) [15]: for example, one woman under-
stood she was obese and had contemplated weight loss
but upon seeing her results in ‘black and white’ subse-
quently took action and reported significant weight loss.
We found a variety of understandings about choles-
terol, diabetes and BMI, which is similar to other work
[16]. Nevertheless, most participants had a good general
understanding of the four results fed back to them
(knowing the lower the better), so it is possible that
understanding of the results among our follow-up study
sample was sufficient but that respondents were enga-
ging in recall only of perceived self-relevant information,
which is similar to other work which fed back choles-
terol information to participants [17].
Limitations
The findings must be considered in the context of var-
ious potential biases: the participants were drawn from
the fifth wave of a longitudinal study and constitute a
potentially highly study-loyal sample - all 50 participants
have remained with the Twenty-07 study over 20 years.
The views of those who ‘drop-out’ could differ from
those of loyal participants - this could have implications
for when and how feedback is offered as part of longitu-
dinal studies. Participants from higher social class
households were overrepresented in the current follow-
up study, although this broadly mirrors the main
Twenty-07 Study sample. Nevertheless, 21 of the 50 par-
ticipants were from households in which the head of
household had a semi or unskilled occupation and no
differences in views between the two groups were
detected in the analysis. It is also possible that social
desirability bias could have been introduced, with some
participants possibly being less candid than others in
their re-telling of their response to their feedback. The
use of telephone interviews along with face-to-face
interviews allowed us to explore any potential respon-
dent bias that might have been associated with the visi-
ble weight status of the researchers; none was apparent
in analyses. The attention paid to the feedback on
weight as compared with other measures (e.g. blood
results and % body fat) suggests that our findings may
not be generalisable to individualised feedback of other
measures. More research is needed to investigate this.
Given the qualitative nature of the follow-up study, and
hence the small numbers, we do not know what propor-
tion of all Twenty-07 Study participants who received a
feedback letter would have implemented behaviour
change in light of their feedback results. Thus, the effect
of feedback on the longer-term validity of longitudinal
studies is not immediately obvious from these data. The
low response rate reveals it was difficult to recruit these
longitudinal study participants to the sub-sample study,
which is perhaps a product of only having recently
exposed participants to a lengthy main study interview
(which lasted an average 2 hours and 43 minutes [18])
and perceptions that their 20-year participation had
come to an end. Participants were not asked if they
would choose to receive the feedback letter again, which
would have assisted in contextualising potential harms
caused.
Implications for future research
We assumed the four results fed back would be clearly
known and understood by participants, being fairly com-
mon measures and the fact the letter they received con-
tained their results against population standard ranges.
However, evidence from this study suggests this may
not be the case and it may be sensible to provide some
additional information about the results fed back, for
example by providing a supplementary leaflet which
explains the measures. Further research should assess
the impact of providing additional information on
understandings and hence the potential enhancement of
the benefit of individualised feedback to participants.
Perhaps counter intuitively, participants described the
weight results having more impact than the blood
results. Perhaps this reflects the easier ‘visibility’ of such
risk factors for subsequent ill-health, rendering them
more available for discussions in day to day discussions
of the implications for future ill-health [19]. Researchers
should tread cautiously in assuming which results could
cause upset in light of sparse empirical evidence on
feeding back individualised data to participants. The
results of this study suggest researchers may wish to
avoid assuming participants will be less affected
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emotionally to the receipt of visible results such as
weight than invisible results (e.g. cholesterol). Careful
wording of feedback letters may therefore be important
to assuage negative impact, for all results whether visible
or invisible. Thus, we concur with Dixon-Woods et al
[5] who call for further evidence on best practice to
avoid ‘assuming that providing research results to parti-
cipants is straightforward’. This underscores the impor-
tance of continuing to monitor the effects of different
types of individualised feedback data on participants.
For example, researchers involved in randomised control
trials may grapple with conveying complex genetic data
to participants in meaningful way (although not all
genetics-based studies need be trials). However, given
the ethical imperative to offer results to study partici-
pants, and the potentially high percentage who will wish
to receive it [4], researchers are increasingly required to
provide clear feedback which will cause minimal harm
to participants, and should consider strategies for giving
additional support, guidance or information to partici-
pants following feedback to help them to interpret their
results.
The existing literature has raised questions about how
best to feed back individualised data within different
types of studies. Although this follow-up study is mod-
erate in size these ethical issues are potentially transfer-
able to other community-based studies which are
feeding back data to participants, for example the Scot-
tish Health Survey, Whitehall studies and the MRC-
funded Caerphilly Prospective Study (CAPS) - UK Bio-
bank also provide participants with individualised results
such as blood pressure and BMI [20]. Thus, a not insig-
nificant number of people are currently receiving (or
potentially will receive) such feedback, so the process of
refinement deserves attention.
Jeffery et al. [21] outlined ethical dilemmas in feeding
back data to participants in a longitudinal study, and the
implications to validity of longitudinal studies. Their
short article offered no conclusion; our study reveals
care is needed in how individualised data are fed back,
as the age and gender differences in response to our
feedback suggest potential non-uniform changes in sub-
sequent observed data. It would seem that the feedback
did, for some, act as an unintended intervention. This
concurs with Dixon-Woods’ assertion that providing
research results ‘constitutes an intervention in its own
right’ [5]. Thus, the non-interventionist nature of longi-
tudinal studies could be compromised. There may be
nothing that researchers can do about this except moni-
tor potential biases and then report them appropriately
in subsequent publications which report subsequent
analyses of the research data. We would recommend
that researchers on longitudinal studies, who provide
results which could change behaviours, perhaps follow-
up a sub-sample to assess the impact feedback may be
having on behaviours so that potential biases are moni-
tored and analyses and dissemination are conducted and
reported accordingly. In addition, it is important to
monitor subsequent participation of different feedback
to inform later waves, as any attrition due to feedback
could affect the response rates and, subsequently, bias.
Conclusions
There remains insufficient evidence in the literature to
determine how best to conduct individualised feedback
as part of non-RCT research to enhance benefits and
reduce harms; in the case of longitudinal studies, it
remains unclear how to reduce potential bias, unin-
tended interventionist effects or impact on subsequent
wave participation. Such effects may vary by study type
as well as by the type of data fed back to respondents.
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